These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 36059510)

  • 1. Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.
    Zhang G; Chen X; Fang J; Tai P; Chen A; Cao K
    Front Immunol; 2022; 13():954440. PubMed ID: 36059510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omics pan-cancer study of cuproptosis core gene
    Xu J; Hu Z; Cao H; Zhang H; Luo P; Zhang J; Wang X; Cheng Q; Li J
    Front Immunol; 2022; 13():981764. PubMed ID: 36605188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma.
    Cai Z; He Y; Yu Z; Hu J; Xiao Z; Zu X; Li Z; Li H
    Front Immunol; 2022; 13():933241. PubMed ID: 36211378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma.
    Guo JS; Ding H; Wu PY; Xin ZY; Li JX; Jo HS; Ma ZH
    Chin Med Sci J; 2023 Sep; 38(3):191-205. PubMed ID: 37503721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma.
    Liu H
    Cancer Genet; 2023 Jun; 274-275():21-25. PubMed ID: 36963335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning.
    Bai Z; Lu J; Chen A; Zheng X; Wu M; Tan Z; Xie J
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration.
    Yao Y; Chen H; Lou M; Chen T
    Front Genet; 2023; 14():1071694. PubMed ID: 36755576
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular Subtyping Based on Cuproptosis-Related Genes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma.
    Ji ZH; Ren WZ; Wang HQ; Gao W; Yuan B
    Front Oncol; 2022; 12():919083. PubMed ID: 35875087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma.
    Luo G; Wang L; Zheng Z; Gao B; Lei C
    Eur J Med Res; 2023 May; 28(1):176. PubMed ID: 37189176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular subtypes based on cuproptosis regulators and immune infiltration in kidney renal clear cell carcinoma.
    Liu A; Li Y; Shen L; Li N; Zhao Y; Shen L; Li Z
    Front Genet; 2022; 13():983445. PubMed ID: 36338990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma.
    Yuan H; Qin X; Wang J; Yang Q; Fan Y; Xu D
    Front Immunol; 2022; 13():971142. PubMed ID: 36131921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis.
    Li D; Wu X; Song W; Cheng C; Hao L; Zhang W
    Ann Transl Med; 2022 Nov; 10(22):1235. PubMed ID: 36544675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analyses of cuproptosis-related gene CDKN2A on prognosis and immunologic therapy in human tumors.
    Zhang D; Wang T; Zhou Y; Zhang X
    Medicine (Baltimore); 2023 Apr; 102(14):e33468. PubMed ID: 37026918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma.
    Wang B; Song Q; Wei Y; Wu X; Han T; Bu H; Tang S; Qian J; Shao P
    Front Immunol; 2022; 13():948042. PubMed ID: 36275737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.
    Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X
    J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma.
    Hong P; Huang W; Du H; Hu D; Cao Q; Wang Y; Zhang H; Tong S; Li Z; Tong M
    Front Genet; 2022; 13():1009555. PubMed ID: 36406128
    [No Abstract]   [Full Text] [Related]  

  • 17. Integrated bioinformatic analysis and cell line experiments reveal the significant role of the novel immune checkpoint TIGIT in kidney renal clear cell carcinoma.
    Xia QD; Li B; Sun JX; Liu CQ; Xu JZ; An Y; Xu MY; Zhang SH; Zhong XY; Zeng N; Ma SY; He HD; Zhang YC; Guan W; Li H; Wang SG
    Front Oncol; 2023; 13():1096341. PubMed ID: 37035135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
    Zhong S; Chen S; Lin H; Luo Y; He J
    BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma.
    Pang Y; Wang Y; Zhou X; Ni Z; Chen W; Liu Y; Du W
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.